Analgesics & NSAIDs Flashcards
S2Q2
ANALGESICS: Opioids
cardinal signs of inflammation (5)
license
morphine, oxycodone, fentanyl, codeine, thedane
- cardinal signs of inflam: pain, redness, swelling, heat, function
- need S2 license
- morphine: gold
- oxycodone: diff color for diff dose
- fentanyl: 75mg continuous transdermal = systemic effect
- codeine: cough
- thedane: poppy heroin; antidote for opioid
ANALGESICS: Opioids
purpose (3)
effects (6.3)
PURPOSE
- mod to severe pain (gr. 4-10)
- bind to neuronal receptors
- potential for physical dependence
EFFECTS
- histamine release, OH, respiratory depression, apnea, bradycardia
- suppressed cough reflex
- euphoria
- constipation
- miosis (pupillary constriction)
- nausea, vomit, sedation, drowsy
ANALGESICS: Opioids
MOA on brain (3)
MOA on spine (2)
MOA on peripheral nerves (1)
MOA on brain
- stimulate neurons for pain modulation, inhibit pain transmission
- bind to nociceptors
MOA on spine
- inhibit nociceptive to higher levels by: dec pain substance, hyperpolarize post-synaptic neurons
MOA on peripheral nerves
- dec excitability of A-delta & C fibers
ANALGESICS: Opioids
Mu - location & effect (4.3)
Kappa - location & effect (3.3)
Delta - location & effect (3.2)
Sigma - location & effect (1.3)
which high/low abuse potential
MU (high)
- supraspinal, periaqueductal gray, hypothalamus, medial thalamic nuclei, limbic system
- supraspinal modulation, euphoria, respiratory depression
KAPPA
- spinal, dorsal horn (substantia gelatinosa), deep layers of cerebral cortex
- spinal modulation, sedation, pressed flexor reflexes
DELTA
- substantia nigra, GP, corpus striatum, limbic
- euphoria, sedation
SIGMA
- hippocampus
- dysphoria, hallucination, cerebrovascular
ANALGESICS: Opioids
poppy seeds law
comprehensive drugs act of 2022
ANALGESICS: Opioids
abstinence syndrome (15)
- sweating, runny nose, sneeze
- fatigue, weakness, insomnia, uncontrolled yawning, irritability,
- tachycardia
- body aches, gooseflesh, shivering
- stomach cramps, diarrhea, bye appetite
ANALGESICS: Non-Opioid
acetaminophen - other name, active what of what, purpose (1.3), indications (3)
- paracetamol
- active metabolite of phenacetin
- anti-pyretic
NOT anti-inflammatory
- no prostaglandin inhibitor
- non-platelet inhibitor
- inhibits cyclooxygenase 3 (COX3)
INDICATIONS
- mild to mod fever
- allergic to aspirin
- fever
ANALGESICS: Non-Opioid
pharmacokinetics - peak concentration, half life, metabolism, metabolites (3)
- peak blood concentration: 30-60 mins
- half life: 2-3h
- metabolism: hepatic microsomal enzyme
METABOLITES
- n-acetyl: nephrotoxic (kidney), hepatotoxic (liver)
- acetaminophen sulfate
- glucuronide
ANALGESICS: Non-Opioid
adverse effects (8)
- inc hepatic enzyme
- dizzy, excitement, disorientation
- central lobular necrosis, renal tubular necrosis (liver)
- hemolytic anemia, methemoglobinemia
NSAIDS:
COX 1 - main = 3 effects
COX 2 = main = 4 effects
COX1 = prostaglandin (homeostatic)
- renal homeostasis
- gastric mucosal production
- platelet
COX 2 = prostaglandin (inflammatory)
- pain
- fever
- inflammation
- little homeostatic effects
NSAIDS:
damage = what substance, what acid = 2 pathways, eicosanoids what
thromboxanes - made by, effect (1=1) (2=1)
leukotrines - effect (2), condition
- damage cell membrane = phospholipid
- arachidonic acid = COX (prostaglandin & thromboxanes) & lipoxygenase (leukotrines)
- eicosanodis: initiate inflammation
THROMBOXANES
- synthesized by platelets
- platelet aggregation = clot
- bronchoconstriction & vasoconstriction = asthma
LEUKOTRINES
- bronchoconstriction, mucus production
- allergic rhinitis = inhibit this
NSAIDS: Aspirin
what, inhibits what by what
anti-inflammatory (4)
- gold standard for NSAIDs
- inhibits prostaglandin synthesis by inhibiting COX enzyme
ANTI-INFLAMMATORY
- inhibits granulocyte from attaching to damaged cells
- stabilizes lysosome
- inhibits migration of leukocyte & macrocyte to inflammatory site
NSAIDS: Aspirin
analgesic - for, how
anti-pyretic - how (1) (1=1=1)
inhibit what & therefore (2)
ANALGESIA
- mild to mod
- peripheral mechanism
ANTI-PYRETIC
- inhibits pyrogen-induced release of prostaglandin
- vasodilate = release heat = cool down
INHIBIT PLATELET AGGREGATION
- stroke & MI mx
NSAIDS: Aspirin
absorption - where (2), peak plasma, protein binding
excretion - how, low dose vs. high dose (2)
dosage - kid vs. adult
ABSORPTION
- small intestine, stomach
- peak plasma concentration: 1-2h
- protein binding: 80-90%
EXCRETION
- urine alkalinization
- low dose: first order, t1/2 = 3-5h
- high dose: zero order, t1/2= 15h
DOSAGE
- kids: 50-70mg/kg/day
- adult: 4g/day
NSAIDS: Aspirin
adverse effects (3.1.2)
- ulceration: GI mucosa irritation, absorb non-ionized salicylate, inhibit protective mechanism
- allergic reaction
- nephrotoxic, hepatotoxic